Cargando…

Cell-based passive immunization for protection against SARS-CoV-2 infection

BACKGROUND: Immunologically impaired individuals respond poorly to vaccines, highlighting the need for additional strategies to protect these vulnerable populations from COVID-19. While monoclonal antibodies (mAbs) have emerged as promising tools to manage infectious diseases, the transient lifespan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawula, Evan, Miersch, Shane, Jong, Eric D., Li, Chengjin, Chou, Fang-Yu, Tang, Jean Kit, Saberianfar, Reza, Harding, Jeffrey, Sidhu, Sachdev S., Nagy, Andras
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629160/ https://www.ncbi.nlm.nih.gov/pubmed/37932852 http://dx.doi.org/10.1186/s13287-023-03556-5

Ejemplares similares

Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
por: Miersch, Shane, et al.
Publicado: (2022)

Intracellular targeting with engineered proteins
por: Miersch, Shane, et al.
Publicado: (2016)

Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa
por: Jong, Eric D., et al.
Publicado: (2023)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
por: Miersch, Shane, et al.
Publicado: (2021)

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
por: Suryamohan, Kushal, et al.
Publicado: (2021)

Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
por: Spitalieri, Paola, et al.
Publicado: (2022)

Structure-based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2
por: Fellouse, Frederic A., et al.
Publicado: (2021)

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
por: Case, James Brett, et al.
Publicado: (2020)

Peptide Platform as a Powerful Tool in the Fight against COVID-19
por: Murdocca, Michela, et al.
Publicado: (2021)

Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern
por: Wang, Tony, et al.
Publicado: (2022)

Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site
por: van Vliet, Vera J. E., et al.
Publicado: (2022)

Protein bodies: how the ER deals with high accumulation of recombinant proteins
por: Saberianfar, Reza, et al.
Publicado: (2017)

Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
por: Xiang, Jiangchao, et al.
Publicado: (2022)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
por: Correia-Neves, Margarida, et al.
Publicado: (2019)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

The role of passive immunization in the age of SARS-CoV-2: an update
por: Fischer, Johannes C., et al.
Publicado: (2020)

Passive swab versus grab sampling for detection of SARS-CoV-2 markers in wastewater
por: West, Nicholas W., et al.
Publicado: (2023)

Global Gene Expression Analysis of Fission Yeast Mutants Impaired in Ser-2 Phosphorylation of the RNA Pol II Carboxy Terminal Domain
por: Saberianfar, Reza, et al.
Publicado: (2011)

A Rationally Designed Bovine IgA Fc Scaffold Enhances in planta Accumulation of a V(H)H-Fc Fusion Without Compromising Binding to Enterohemorrhagic E. coli
por: Chin-Fatt, Adam, et al.
Publicado: (2021)

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
por: Hammarström, Lennart, et al.
Publicado: (2020)

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023)

Correction to: The role of passive immunization in the age of SARS-CoV-2: an update
por: Fischer, Johannes C., et al.
Publicado: (2020)

Passively sensing SARS-CoV-2 RNA in public transit buses
por: Hoffman, Jason S., et al.
Publicado: (2022)

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
por: Focosi, Daniele, et al.
Publicado: (2023)

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters
por: Lu, Mijia, et al.
Publicado: (2021)

A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice
por: Chaparian, Ryan R., et al.
Publicado: (2022)

Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes
por: Ye, Chengjin, et al.
Publicado: (2022)

Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2
por: Barbier, Mariette, et al.
Publicado: (2022)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
por: Chai, Kit Man, et al.
Publicado: (2021)

Do Dogs and Cats Passively Carry SARS-CoV-2 on Hair and Pads?
por: Lauzi, Stefania, et al.
Publicado: (2021)

Will Passive Protection Save Congo Forests?
por: Galford, Gillian L., et al.
Publicado: (2015)

Passive Immunisation against RHDV2 Induces Protection against Disease but Not Infection
por: Hall, Robyn N., et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Correction: DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
por: Chai, Kit Man, et al.
Publicado: (2023)

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
por: Miczi, Márió, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_36mi9r3u6c8sbshggog968jv17